Day: August 25, 2022

Ublituximab is an investigational targeted B-cell therapy that shows superior efficacy when compared with teriflunomide, a commonly prescribed oral treatment for multiple sclerosis ULTIMATE I and II demonstrated significant reductions in risk of relapses, as well as reduction of active or new brain lesions The US Food and Drug Administration and European Medicines Agency are currently reviewing marketing applications for ublituximab for the treatment of relapsing forms of multiple sclerosis (RMS) in adults If approved, ublituximab will be the first B-cell therapy for use in RMS patients that can be given as a 1- hour infusion every 6 months, following the first dose NEW YORK, Aug. 25, 2022 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced results from the ULTIMATE I & II Phase 3 trials evaluating ublituximab,...

Expanding services and offerings to the infectious disease community throughout the U.S. provides revenue growth opportunity Services at launch include rapid turnaround sequencing of clinical isolates, unique and differentiated interpretative services and the proprietary AREScloud web application for outbreak analysisROCKVILLE, Md., Aug. 25, 2022 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that it has launched next generation sequencing (NGS) services in the U.S. that were developed by its subsidiary, Ares Genetics (“Ares”), which strives to become a leader in bacterial genomics and artificial intelligence (AI)-powered antimicrobial resistance (AMR) solutions. The...

Jushi Opens Fourth Dispensary in Virginia Jushi Holdings Inc. announced the opening of its fourth medical cannabis dispensary in Virginia and 35th retail location nationwide. Beyond Hello™ Fairfax will begin serving medical cannabis patients and registered agents on Wednesday, August 31st at 10:00 a.m. in-store and through its digital retail experience at beyond-hello.comBeyond Hello™ Fairfax Expands Patient Access in Virginia Located at 10521 Fairfax Blvd. in Fairfax near the corner of Lee Highway and Rt. 123 and just blocks from I-66, Beyond Hello™ Fairfax features 16 traditional and 10 express patient checkouts, along with 45 parking spots with easy in-and-out access to improve patient convenience and accessibility.Virginia Dispensary to Carry Variety of Medical Cannabis Products Beyond Hello™ Fairfax will offer dry leaf,...

Locally owned Indiana lender will leverage SimpleNexus’ homeownership platform as a competitive advantage with tech-savvy consumers LEHI, Utah, Aug. 25, 2022 (GLOBE NEWSWIRE) — SimpleNexus (https://simplenexus.com/), an nCino (NASDAQ: NCNO) company and developer of the leading U.S. homeownership platform for loan officers, borrowers, real estate agents and settlement agents, today announced that Approved Mortgage has selected SimpleNexus as its point-of-sale (POS) solution. The Indiana-based lender will use SimpleNexus’ mobile-first feature set to enhance its services to clients and real estate professionals while streamlining its internal processes. Thirty years in operation, Approved Mortgage is central Indiana’s oldest and largest locally owned mortgage bank, with over $6.5 billion in loans funded to date. Approved Mortgage...

GBT’s first continuation patent strengthening the new multi-dimensional integrated circuit’s architecture and manufacturing concepts Patent Granted on August 9, 2022 SAN DIEGO, Aug. 25, 2022 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT” or the “Company”), first 3D, Multi-Planar IC design and manufacturing technology, continuation patent, was granted by the United States Patent and Trademark Office (“USPTO”) on August 9, 2022. The first continuation patent is focused on strengthening the new microchip’s design and manufacturing concepts and methodologies. A second continuation patent was filed on July 29, 2022, seeking to protect the memory integrated circuit’s architecture and connectivity structures. The original nonprovisional patent protects a system and method to design and manufacture microchips on...

– Investigational New Drug Application for CNTY-101, a CAR-iNK product candidate targeting CD19 for B-cell malignancies, cleared by FDA – – First cell product candidate engineered with six precision gene edits including a CD19-CAR, Allo-Evasion™ technology, IL-15 cytokine support and a safety switch – – Phase 1 ELiPSE-1 trial evaluating CNTY-101 in relapsed or refractory CD19 positive B-cell malignancies anticipated to begin in 2H22 – PHILADELPHIA, Aug. 25, 2022 (GLOBE NEWSWIRE) — Century Therapeutics, Inc., (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, announced today that the company has been notified by the U.S. Food and Drug Administration (FDA) that the Company’s ELiPSE-1 clinical study may proceed to assess CNTY-101 in patients...

DETROIT, Aug. 25, 2022 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform and content creation services for business, university, non-profit, and government agency learning and upskilling, announces today it is launching the Conner Prairie Learning Portal to deliver eLearning powered by Amesite on Monday, August 29, 2022. The launch features the course “Exploring Your Curiosity Through Storytelling”. The Conner Prairie Learning Portal, an online Learning Community Environment® (LCESM), will offer K-12 programs for teachers, parents, and students, all delivered in a digital, easy-to-use, and collaborative format. New capabilities on Conner Prairie’s LCESM include a 3D interactive virtual tour of Conner Prairie using SCORM (Dynamic Lecture) content...

ARLINGTON, Va., Aug. 25, 2022 (GLOBE NEWSWIRE) — Edge Total Intelligence Inc. (“edgeTI”), a leading provider of real-time digital operations software, today announced it has partnered with OnSolve, a leading critical event management provider that helps organizations mitigate physical threats and remain agile when a crisis strikes, to deliver comprehensive situational awareness and response and critical event management to edgeTI customers. OnSolve’s AI-driven risk intelligence and critical communications integrated into edgeTI’s platform gives full operational visibility and control for companies looking to achieve organizational resilience. The strategic partnership establishes referral relationships between each company’s sales teams and formalizes the integration of OnSolve’s advanced risk intelligence and critical...

Please find enclosed the presentation of Golden Ocean Group Limited’s second quarter 2022 results for today’s webcast / conference call at 16:00 CET. Attend by Webcast: Use to the follow link prior to the webcast: GOGL Q2 2022 Webcast Attend by Conference Call: Participants will need to register online prior to the conference call via the link below. Dial-in details will be available when registered. GOGL Q2 2022 Conference Call A Q&A session will be held after the conference call/webcast. Information on how to submit questions will be given at the beginning of the session. The presentation material which will be used in the teleconference/webcast can be downloaded on www.goldenocean.bm and replay details will also be available at this website. This information is subject to the disclosure requirements pursuant to Section 5-12...